Partnering with pharmacists ensures prescription availability for patients with HIV during the coronavirus disease 2019 (COVID-19), noted Milena Murray, PharmD, MSc, BCIDP, AAHIVP, of Midwestern University College of Pharmacy.
Partnering with community pharmacists helps to ensure patients can pick up their prescriptions, especially if there are fill issues at our specialty pharmacy, noted Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University Chicago College of Pharmacy, who practices at the Northwestern Medicine Infectious Disease Center in Chicago.
Transcript
How have your patient interactions changed now that the HIV epidemic overlaps with the coronavirus disease 2019 pandemic?
There’s so much more phone interaction. So, a lot of the times the patients aren’t coming into the clinic and we’re calling them on the phone, whether it’s for an adherence check or counseling, or whatever it may be. And that’s really helpful, because then we can touch base serially with the patient and we’re not waiting for them to come to us.
How do your responsibilities differ from those of a more generalized community pharmacist?
As an ambulatory care pharmacist, partnering with community pharmacies and pharmacists is so important, because that’s the point of dispense if the patients aren’t able to fill at our specialty pharmacy, so I really get involved before the prescription goes out. So, are there drug interactions? Patient preferences? Is the tablet too large for them to swallow? And any other criteria. And then on the community side, they’re more involved after the prescription has been sent.
And so, we try to partner with them then to make sure, what was the co-pay? Did it go through the insurance? Is there a prior authorization need? And then, at that point, the patient would be able to pick up the prescription.
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
As Claims Denials Surge, AI and Data-Driven Insights Equip Clinicians, Hospitals to Fight Back
March 13th 2025As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in shaping the future of patient care, according to experts from Komodo Health and SmarterDx.
Read More
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
March 13th 2025Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Read More